Department of Abdominal Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Department of Vascular Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Eur J Vasc Endovasc Surg. 2019 Jun;57(6):842-849. doi: 10.1016/j.ejvs.2019.01.002. Epub 2019 May 22.
Despite modern advances in diagnosis and treatment, acute arterial mesenteric ischaemia (AMI) remains a high mortality disease. One of the key modifiable factors in AMI is the first door to operation time, but the factors attributing to this parameter are largely unknown. The aim of this study was to evaluate the factors affecting delay, with special focus on the pathways to treatment.
This was a single academic centre retrospective study. Patients undergoing intervention for AMI caused by thrombosis or embolism of the superior mesenteric artery between 2006 and 2015 were identified from electronic patient records. Patients not eligible for intervention or with chronic, subacute onset, colonic only, venous, or non-occlusive mesenteric ischaemia were excluded. Patients were divided into two groups according to the first speciality examining the patient (surgical emergency room [SER], surgeon examining the patient first or non-surgical emergency room [non-SER], internist examining the patient first). The primary endpoint was first door to operation time and secondary endpoints were length of stay and 90 day mortality.
Eighty-one patients with AMI were included. Fifty patients (62%) died during the first 30 days and 53 (65%) within 90 days. Presenting first in non-SER (vs. SER) was independently associated with a first door to operation time of over 12 h (OR 3.7 [95% CI 1.3-10.2], median time 15.2 h [IQR 10.9-21.2] vs. 10.1 h [IQR 6.9-18.5], respectively, p = .025). The length of stay was shorter (median 6.5 days [4.0-10.3] vs. 10.8 days [7.0-22.3], p = .045) and 90 day mortality was lower in the SER group (50.0% vs. 74.5%, p = .025).
The first specialty that the patient encounters seems to be crucial for both delayed management and early survival of AMI. Developing fast/direct pathways to a unit with both gastrointestinal and vascular surgeons offers the possibility of improving the outcome of AMI.
尽管现代诊断和治疗技术取得了进步,但急性肠系膜动脉缺血(AMI)仍然是一种高死亡率疾病。AMI 中一个关键的可改变因素是首次手术时间,但导致这一参数的因素在很大程度上尚不清楚。本研究旨在评估影响延迟的因素,特别关注治疗途径。
这是一项单中心回顾性研究。从电子病历中确定了 2006 年至 2015 年间因肠系膜上动脉血栓形成或栓塞而接受介入治疗的 AMI 患者。排除不符合介入治疗条件或为慢性、亚急性发病、仅累及结肠、静脉或非闭塞性肠系膜缺血的患者。根据首次检查患者的科室(外科急诊室[SER],首先检查患者的外科医生或非外科急诊室[非 SER],首先检查患者的内科医生)将患者分为两组。主要终点是首次手术时间,次要终点是住院时间和 90 天死亡率。
共纳入 81 例 AMI 患者。50 例(62%)患者在 30 天内死亡,53 例(65%)患者在 90 天内死亡。非 SER 首次就诊(与 SER 相比)与首次手术时间超过 12 小时独立相关(OR 3.7 [95%CI 1.3-10.2],中位时间 15.2 小时 [IQR 10.9-21.2] 与 10.1 小时 [IQR 6.9-18.5] 相比,p=0.025)。SER 组的住院时间更短(中位数 6.5 天 [4.0-10.3] 与 10.8 天 [7.0-22.3] 相比,p=0.045),90 天死亡率也更低(50.0%与 74.5%相比,p=0.025)。
患者首次就诊的科室似乎对 AMI 的延迟治疗和早期生存都至关重要。建立一个有胃肠外科医生和血管外科医生的单位的快速/直接途径提供了改善 AMI 结局的可能性。